Literature DB >> 14533285

Management of COPD according to guidelines. A national survey among Belgian physicians.

M Decramer1, P Bartsch, R Pauwels, J C Yernault.   

Abstract

Current management of COPD by Belgian physicians was compared with the recommendations of the recently published GOLD guidelines. A random sample of 386 general practitioners and 86 pulmonologists filled in a questionnaire based on the GOLD guidelines and examining their attitudes towards COPD management. Several important deviations from the guidelines were noted. Only few GP's performed spirometry themselves and about 55% of the diagnoses were not based on spirometry. Both GP's and pulmonologists used inhaled corticosteroids considerably more often than prescribed by the guidelines, with 49% and 25% respectively, prescribing them to all COPD patients. Chronic systemic steroids were also overused in stable disease, with 55% of the GP's and 52% of the pulmonologists prescribing them in patients with repeated exacerbations. GP's did not use enough systemic corticosteroids and overused antibiotics in the treatment of exacerbations. Pulmonologists did not pay enough attention to pulmonary rehabilitation, as only 44% of them had a structured programme. Pulmonologists did not use non-invasive ventilation frequently enough in the treatment of exacerbations, as only 22% would use it in the correct indication. Both GP's and pulmonologists did not prescribe enough pharmacotherapy for smoking cessation, with 35% and 46%, respectively using it. Some interesting differences between Dutch and French speaking physicians were noted. These specific deviations from the guidelines will be addressed in a second phase implementation project.

Entities:  

Mesh:

Year:  2003        PMID: 14533285

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  21 in total

1.  Hospital pharmacists' awareness of a new antibiotic guideline in the UK: implications for practice.

Authors:  Eleanor M Woodford; Keith A Wilson; John F Marriott
Journal:  Pharm World Sci       Date:  2005-06

2.  Spirometry in chronic obstructive pulmonary disease.

Authors:  Patrick J P Poels; Tjard R J Schermer; Chris van Weel; Peter M A Calverley
Journal:  BMJ       Date:  2006-10-28

3.  Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Miguel Angel Gil de; Rodrigo Jimenez-Garcia
Journal:  Lung       Date:  2011-04-17       Impact factor: 2.584

4.  Must family physicians use spirometry in managing asthma patients?: NO.

Authors:  Anthony D D'Urzo
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

5.  From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.

Authors:  Raffaele Antonelli Incalzi; Andrea Corsonello; Claudio Pedone; Giulio Masotti; Vincenzo Bellia; Vittorio Grassi; Franco Rengo
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

7.  EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit.

Authors:  Mir S Adil; M Amer Khan; M Nematullah Khan; Ihtisham Sultan; M Aamer Khan; S Amir Ali; Afroze Farooqui
Journal:  J Clin Diagn Res       Date:  2015-11-01

8.  The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial.

Authors:  Kris Vanhaecht; Walter Sermeus; Jan Peers; Cathy Lodewijckx; Svin Deneckere; Fabrizio Leigheb; Marc Decramer; Massimiliano Panella
Journal:  Trials       Date:  2010-11-19       Impact factor: 2.279

9.  Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Authors:  Carl Victor Asche; Shelah Leader; Craig Plauschinat; Swetha Raparla; Ming Yan; Xiangyang Ye; Dave Young
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-03-15

10.  Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.

Authors:  Rupert C M Jones; Maria Dickson-Spillmann; Martin J C Mather; Dawn Marks; Bryanie S Shackell
Journal:  Respir Res       Date:  2008-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.